Medroxyprogesterone PCD Pharma Franchise Company
Cafoli Lifecare is a trusted Medroxyprogesterone PCD pharma franchise company in India, offering 2 Medroxyprogesterone formulations manufactured at WHO-GMP certified facilities. The range is supplied in oral tablet form, making it a focused, easy-to-stock addition to any gynaecology franchise portfolio.
What is Medroxyprogesterone?
Medroxyprogesterone acetate is a synthetic progestin — a derivative of progesterone that binds progesterone receptors and produces secretory transformation of an oestrogen-primed endometrium. It is used to treat abnormal uterine bleeding, secondary amenorrhoea and endometriosis, and as a component of hormone therapy and contraception. Medroxyprogesterone acetate appears on the WHO Model List of Essential Medicines.
Therapeutic Applications
Medroxyprogesterone tablets are used in the management of abnormal or dysfunctional uterine bleeding, secondary amenorrhoea, endometriosis and endometrial hyperplasia, and as the progestin component of hormone therapy regimens. Prescribing is concentrated among gynaecologists and obstetricians, with additional use by endocrinologists and general physicians managing menstrual disorders.
Why Medroxyprogesterone is a High-Potential Molecule for Distributors
Medroxyprogesterone is a specialist molecule with an outsized strategic value: it is a door-opener into the gynaecology channel. Gynaecologists are among the most valuable prescriber lists in Indian pharma because their patients are on long-term, repeat, largely self-paying therapy — and a distributor who can reliably supply a WHO-listed essential progestin earns credibility to introduce the rest of a women's-health range (calcium, iron, folic acid, progesterone, contraceptives). With only two SKUs, the inventory commitment is minimal while the relationship value is high. Being an essential medicine also means steady, non-seasonal baseline demand.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers exclusive monopoly rights in your territory, WHO-GMP certified and DCGI-approved manufacturing, dependable stock availability, competitive margins, and complete promotional support including visual aids, samples, MR bags, catch covers and reminder cards. We support 1000+ franchise partners across India.
References
- WHO Model List of Essential Medicines
- PubChem — Medroxyprogesterone Acetate Compound Summary, National Library of Medicine
- PubMed — Clinical literature on Medroxyprogesterone
Our formulations of Medroxyprogesterone find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: